2015, Number 2
<< Back
Rev Odont Mex 2015; 19 (2)
Endodontic patient with rhinocerebral mucormycosis: clinical case report
Hernández MH, Rodríguez HA
Language: Spanish
References: 16
Page: 121-126
PDF size: 751.66 Kb.
ABSTRACT
A patient previously diagnosed with cerebral mucormycosis attended the Endodontics Clinic of the Graduate and Research School, National School of Dentistry, National University of Mexico (UNAM). This article presents variations in the clinical handling of the patient; stress is made on the importance of preserving the greatest number of teeth in the mouth to thus achieve better stability of the palatal obturator and establish suitable phonation and mastication functions.
REFERENCES
Pía W, Spalloni M, Glaser S, Verdugo P. Mucormicosis rinocerebral, sobrevida en un niño con leucemia. Rev Chil Infect. 2004; 21: 53-56.
Sugar AM. Agentes de la mucormicosis y especies relacionadas. En: Mandell GL, Bennett JE, Dolin R Eds. Enfermedades infecciosas. Principios y práctica. 4a ed. Buenos Aires, Argentina: Médica Panamericana; 1997: pp. 2595-2606.
Wiedermann BL. Zigomicosis. En: Feigin RD, Cherry JD (Eds). Tratado de infecciones en pediatría. 4a ed. México, DF: Interamericana McGraw-Hill; 1995: pp. 2180-2186.
Rippon JW. Zygomycosis. In: Rippon JW (Ed). Medical mycology. The pathogenic actinomycetes. 3rd ed. Philadelphia: WB Saunders; 1988: pp. 697-703.
Scholer HJ, Müller E, Schipper MA. Mucorales. The pathogenic species of mucor. Occurrence as pathogens. In: Howard DH, Howard LF (Eds). Fungi pathogenic for humans and animals. New York: Marcel Deckker; 1983: pp. 44-45.
Neame P, Rayner D. Mucormycosis. Arch Pathol. 1960; 70: 143-150.
Kwon-Chung KJ, Bennett JE. Mucormycosis. Medical mycology. Philadelphia: Lea Febiger; 1992: pp. 524-559.
Tedder M, Spratt JA, Anstadt MP. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994; 57: 1044-1050.
Arnáiz ME, Alonso D, González MC, García JD, Sanz JR, Arnáiz AM. Cutaneous mucormycosis: report of fi ve cases and review of the literature. J Plast Reconstr Aesthet Surg. 2009; 62: 434- 441.
Méndez-Tovar LJ. Unidad de Investigación Médica, Hospital de Especialidades C.M.N. Siglo XXI. UNAM, 2011.
Petrikkos G, Skiada A, Lortholaryet O. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54 (S1): S23-34.
Barron-Soto MA, Campos-Navarro LA. Morbilidad y mortalidad del paciente con mucormicosis rinorbitaria posterior al tratamiento médico quirúrgico oportuno. Cir Ciruj. 2001; 69: 8-11.
Jung SH, Kim SW, Park ChS, Song ChE, Cho JH, Lee JH et al. Rhinocerebral mucormycosis: consideration of prognostic factors and treatment modality. Auris Nasus Larynx. 2009; 36: 274- 279.
Terk MR et al. MRI imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation. Magn Reson Imaging. 1992; 10: 81-7.
Garces P, Mueller D, Trevenen C. Rhinocerebral mucormycosis in a child with leukemia: CT and MRI fi ndings. Pediatr Radiol. 1994; 24: 50-51.
Rodríguez-Hidalgo A, Jácome-Musule JL, García-Aranda LR. Murcomicosis oral y su implicación endodóncicas. Endodoncia. 1998; 2: 9-12.